Fintel reports that on November 5, 2024, Piper Sandler initiated coverage of Camp4 Therapeutics (NasdaqGM:CAMP) with a Overweight recommendation. Analyst Price Forecast Suggests 173.74% Upside As of ...

Don Schneider, Piper Sandler deputy head of U.S. policy, joins CNBC's 'The Exchange' to discuss portfolio positioning ahead ...

In a report released today, Peter Keith from Piper Sandler maintained a Hold rating on Dollar Tree (DLTR – Research Report), with a price ...

The British drugmaker’s unit RBP Global Holdings Ltd. signed up with Piper Sandler Finance LLC and certain buyers for $400 ...

In a report released today, Matthew Farrell CFA from Piper Sandler reiterated a Hold rating on Vivid Seats (SEAT – Research Report), with ...

Ann Miller will lead global sports marketing, and Chief Supply Chain Officer Venkatesh Alagirisamy will be elevated to the ...

Microsoft stock fell after guidance disappointed investors. Analysts see strong demand and AI revenue opportunities for the future.

On Wednesday, Olaplex Holdings Inc (OLPX) stock saw a decline, ending the day at $2.06 which represents a decrease of $-0.06 or -2.83% from the prior close of $2.12. The stock opened at $2.1 and ...

On Monday, Akebia Therapeutics Inc (AKBA) stock saw a modest uptick, ending the day at $1.63 which represents a slight increase of $0.04 or 2.52% from the prior close of $1.59. The stock opened at $1.

We recently compiled a list of the 10 AI News Investors Should Not Miss. In this article, we are going to take a look at ...

Boston Beer (NYSE:SAM – Free Report) had its price objective boosted by Piper Sandler from $325.00 to $330.00 in a research ...

Piper Sandler also addresses the intersection of momentum with quality stocks. They emphasize that quality strategies, which ...